Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue

Background: Pancreatic cancer has a poor prognosis. Because the response to existing therapies is limited, gene therapy may offer a new approach to treatment. Efficient adenovirus infection of target cells depends upon the presence of the Coxsackie and adenovirus surface receptor CAR. Aim: To evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Verbeke, C. S., Hamdan, S., Booth, J., Pandha, H. S., Blair, G. E.
Format: Conference or Workshop Item
Language:en
Published: 2006
Subjects:
Online Access:http://eprints.utm.my/2090/1/PanCClub.pdf
http://eprints.utm.my/2090/
http://www.karger.com/doi/10.1159/000093601
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1845470611750518784
author Verbeke, C. S.
Hamdan, S.
Booth, J.
Pandha, H. S.
Blair, G. E.
author_facet Verbeke, C. S.
Hamdan, S.
Booth, J.
Pandha, H. S.
Blair, G. E.
author_sort Verbeke, C. S.
building UTM Library
collection Institutional Repository
content_provider Universiti Teknologi Malaysia
content_source UTM Institutional Repository
continent Asia
country Malaysia
description Background: Pancreatic cancer has a poor prognosis. Because the response to existing therapies is limited, gene therapy may offer a new approach to treatment. Efficient adenovirus infection of target cells depends upon the presence of the Coxsackie and adenovirus surface receptor CAR. Aim: To evaluate the potential efficacy of adenoviral therapy in pancreatic cancer, we evaluated expression of CAR in human pancreatic cancer cell lines and archival tissues of pancreatic cancer and normal pancreas. Method: Surface CAR expression in 10 human pancreatic cancer cell lines was analysed by flow cytometry following treatment with a polyclonal rabbit anti-CAR antibody. CAR expression was correlated with the efficiency of transduction of these cell lines with recombinant Ad5CMVEGFP virus. Using the same antibody, immunostaining was performed on tissue microarrays containing 188 pancreatic ductal adenocarcinomas and 68 matched controls. Results: The level of surface CAR expression varied amongst the pancreatic cancer cell lines, and correlated with their susceptibility to adenoviral transduction. Immunostaining for CAR was absent in 103 (55%) of adenocarcinomas, while moderate and strong staining was observed in 59 (31%) and 26 (14%) cases, respectively. Absence of CAR immunolabeling correlated with poor histological differentiation and clear cell morphology of pancreatic cancer. In normal tissue, strong immunolabeling was seen in the majority of islet cells as well as in peripheral and interlobular pancreatic ducts. Conclusion: Absence of CAR expression in a considerable proportion of pancreatic cancers and constitutive CAR expression in normal pancreatic tissue may reduce the suitability of adenoviral gene therapy in pancreatic cancer patients.
format Conference or Workshop Item
id my.utm.eprints-2090
institution Universiti Teknologi Malaysia
language en
publishDate 2006
record_format eprints
spelling my.utm.eprints-20902017-08-27T00:17:50Z http://eprints.utm.my/2090/ Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue Verbeke, C. S. Hamdan, S. Booth, J. Pandha, H. S. Blair, G. E. Q Science (General) Background: Pancreatic cancer has a poor prognosis. Because the response to existing therapies is limited, gene therapy may offer a new approach to treatment. Efficient adenovirus infection of target cells depends upon the presence of the Coxsackie and adenovirus surface receptor CAR. Aim: To evaluate the potential efficacy of adenoviral therapy in pancreatic cancer, we evaluated expression of CAR in human pancreatic cancer cell lines and archival tissues of pancreatic cancer and normal pancreas. Method: Surface CAR expression in 10 human pancreatic cancer cell lines was analysed by flow cytometry following treatment with a polyclonal rabbit anti-CAR antibody. CAR expression was correlated with the efficiency of transduction of these cell lines with recombinant Ad5CMVEGFP virus. Using the same antibody, immunostaining was performed on tissue microarrays containing 188 pancreatic ductal adenocarcinomas and 68 matched controls. Results: The level of surface CAR expression varied amongst the pancreatic cancer cell lines, and correlated with their susceptibility to adenoviral transduction. Immunostaining for CAR was absent in 103 (55%) of adenocarcinomas, while moderate and strong staining was observed in 59 (31%) and 26 (14%) cases, respectively. Absence of CAR immunolabeling correlated with poor histological differentiation and clear cell morphology of pancreatic cancer. In normal tissue, strong immunolabeling was seen in the majority of islet cells as well as in peripheral and interlobular pancreatic ducts. Conclusion: Absence of CAR expression in a considerable proportion of pancreatic cancers and constitutive CAR expression in normal pancreatic tissue may reduce the suitability of adenoviral gene therapy in pancreatic cancer patients. 2006-06-06 Conference or Workshop Item PeerReviewed application/pdf en http://eprints.utm.my/2090/1/PanCClub.pdf Verbeke, C. S. and Hamdan, S. and Booth, J. and Pandha, H. S. and Blair, G. E. (2006) Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue. In: 38th Europian Pancreatic Club (EPC) Meeting, 7-10, June 2006, Tampere, Findland. http://www.karger.com/doi/10.1159/000093601
spellingShingle Q Science (General)
Verbeke, C. S.
Hamdan, S.
Booth, J.
Pandha, H. S.
Blair, G. E.
Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title_full Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title_fullStr Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title_full_unstemmed Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title_short Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
title_sort expression of the coxsackie and adenovirus receptor (car) in pancreatic cancer and normal pancreatic tissue
topic Q Science (General)
url http://eprints.utm.my/2090/1/PanCClub.pdf
http://eprints.utm.my/2090/
http://www.karger.com/doi/10.1159/000093601
url_provider http://eprints.utm.my/